gujarat-terce-laboratoriesGujarat Terce Laboratories Ltd.

₹57.75+15.92%

Market Cap

₹0.00 Cr

Stock P/E

0.00

ROCE

0.00%

ROE

0.00%

Book Value

₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Financially Stressed

Gujarat Terce Laboratories Ltd. exhibits poor financial performance with no growth metrics, negative PE ratio, and no returns on equity or assets, making it a weak contender in the Pharmaceuticals & Drugs sector. In contrast, peers like Sun Pharmaceutical Industries and Cipla demonstrate strong profitability and growth, highlighting Gujarat Terce's underperformance and financial distress.

Key Points

• Gujarat Terce Laboratories shows no revenue growth and negative PE, indicating financial distress.
• Top peers like Sun Pharma and Cipla exhibit strong revenue growth and profitability metrics.
• Value picks identified as those with low PE and high ROE, contrasting with Gujarat's financial weaknesses.

Top Performers

Cipla Ltd.

Strong revenue growth (13.28% YoY), robust ROE (16.63%), and a reasonable PE (23.73) indicate high profitability.

Sun Pharmaceutical Industries Ltd.

High profitability with a ROE of 16.13% and strong revenue growth (8.42% YoY) despite a high PE ratio.

Dr. Reddy's Laboratories Ltd.

Solid revenue growth (16.54% YoY) and a strong ROE (21.76%) with a low PE ratio (15.50) make it attractive.

Explore

Watchlists

Command Palette